BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 16222912)

  • 21. Conduct disorder: diagnosis and treatment in primary care.
    Searight HR; Rottnek F; Abby SL
    Am Fam Physician; 2001 Apr; 63(8):1579-88. PubMed ID: 11327435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emotional processing in male adolescents with childhood-onset conduct disorder.
    Herpertz SC; Huebner T; Marx I; Vloet TD; Fink GR; Stoecker T; Shah NJ; Konrad K; Herpertz-Dahlmann B
    J Child Psychol Psychiatry; 2008 Jul; 49(7):781-91. PubMed ID: 18598245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychiatric disorders and behavioral problems in children and adolescents with Tourette syndrome.
    Ghanizadeh A; Mosallaei S
    Brain Dev; 2009 Jan; 31(1):15-9. PubMed ID: 18558469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of behavioral/developmental disorders comorbid with conduct disorder.
    Harada Y; Hayashida A; Hikita S; Imai J; Sasayama D; Masutani S; Tomita T; Saitoh K; Washizuka S; Amano N
    Psychiatry Clin Neurosci; 2009 Dec; 63(6):762-8. PubMed ID: 20021630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortisol awakening response in healthy children and children with ADHD: impact of comorbid disorders and psychosocial risk factors.
    Freitag CM; Hänig S; Palmason H; Meyer J; Wüst S; Seitz C
    Psychoneuroendocrinology; 2009 Aug; 34(7):1019-28. PubMed ID: 19278790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attention-deficit/hyperactivity disorder: management.
    Szymanski ML; Zolotor A
    Am Fam Physician; 2001 Oct; 64(8):1355-62. PubMed ID: 11681777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attention-deficit/hyperactivity disorder: a selective overview.
    Biederman J
    Biol Psychiatry; 2005 Jun; 57(11):1215-20. PubMed ID: 15949990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The clinical semiology of attention deficit hyperactivity disorder according to age, and the effectiveness of treatments at different ages].
    García-Pérez A; Expósito-Torrejón J; Martínez-Granero MA; Quintanar-Rioja A; Bonet-Serra B
    Rev Neurol; 2005 Nov 1-15; 41(9):517-24. PubMed ID: 16254857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-occurrence of conduct disorder and depression in a clinic-based sample of boys with ADHD.
    Drabick DA; Gadow KD; Sprafkin J
    J Child Psychol Psychiatry; 2006 Aug; 47(8):766-74. PubMed ID: 16898990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship of attention deficit hyperactivity disorder and conduct disorder to juvenile delinquency: legal implications.
    Foley HA; Carlton CO; Howell RJ
    Bull Am Acad Psychiatry Law; 1996; 24(3):333-45. PubMed ID: 8889133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attention-deficit hyperactivity disorder -- bipolar comorbidity in children and adolescents.
    Masi G; Perugi G; Toni C; Millepiedi S; Mucci M; Bertini N; Pfanner C
    Bipolar Disord; 2006 Aug; 8(4):373-81. PubMed ID: 16879138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between trait anxiety and psychopathological characteristics of children at high risk for severe antisocial development.
    Polier GG; Herpertz-Dahlmann B; Matthias K; Konrad K; Vloet TD
    Atten Defic Hyperact Disord; 2010 Dec; 2(4):185-93. PubMed ID: 21432605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):42-51. PubMed ID: 25886655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
    Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Test of four hypotheses for the comorbidity of attention-deficit hyperactivity disorder and conduct disorder.
    Schachar R; Tannock R
    J Am Acad Child Adolesc Psychiatry; 1995 May; 34(5):639-48. PubMed ID: 7775359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comorbidity as a predictor and moderator of treatment outcome in youth with anxiety, affective, attention deficit/hyperactivity disorder, and oppositional/conduct disorders.
    Ollendick TH; Jarrett MA; Grills-Taquechel AE; Hovey LD; Wolff JC
    Clin Psychol Rev; 2008 Dec; 28(8):1447-71. PubMed ID: 18973971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for DSM-IV externalizing disorders with the Child Behavior Checklist: a receiver-operating characteristic analysis.
    Hudziak JJ; Copeland W; Stanger C; Wadsworth M
    J Child Psychol Psychiatry; 2004 Oct; 45(7):1299-307. PubMed ID: 15335349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attention-deficit hyperactivity disorder in adults.
    Bellak L; Black RB
    Clin Ther; 1992; 14(2):138-47. PubMed ID: 1351794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conduct disorder in referred children and adolescents: clinical and therapeutic issues.
    Masi G; Milone A; Manfredi A; Pari C; Paziente A; Millepiedi S
    Compr Psychiatry; 2008; 49(2):146-53. PubMed ID: 18243886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder.
    Riggs PD; Leon SL; Mikulich SK; Pottle LC
    J Am Acad Child Adolesc Psychiatry; 1998 Dec; 37(12):1271-8. PubMed ID: 9847499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.